Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer
Clinical trial NCT02125084 · COMPLETED
Trial details
- NCT number
- NCT02125084
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2021-05-03
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.